# Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)

> **NCT01079312** · PHASE4 · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 80 (actual)

## Conditions studied

- Endoscopic Retrograde Cholangiopancreatography

## Interventions

- **DEVICE:** infusion pump
- **DEVICE:** infusion pump for patient-controlled sedation
- **DRUG:** propofol
- **DRUG:** fentanyl
- **DRUG:** sedative mixture
- **DRUG:** remifentanil hydrochlorid

## Key facts

- **NCT ID:** NCT01079312
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079312, "Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01079312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*